Address: 8/2 Bolshaya Moskovskaya Str., Suite 4-1, St.Petersburg, 191002, Russia
Tel: +7 (812) 449 86 34
Web: http://www.oct-clinicaltrials.com/
Headquartered in St-Petersburg, Russia, OCT is a full-service contract research organization (CRO) providing high-quality services in clinical trials conduct in Central and Eastern Europe (CEE).
Since 2005 we have made several steps to become the company we are today and to extend our footprint in Central and Eastern Europe. Our qualified clinical team includes medical doctors and R&D professionals in Russia, Ukraine, Bulgaria, Belarus, Latvia, Lithuania, Estonia, Poland and Czech Republic.
Although most of the clinical trials conducted at OCT in Central and Eastern Europe were rescue studies for which recruitment was slow, now many OCT sponsors realize that this region should be highly considered when initiating global clinical trials. OCT have extensive experience in a wide range of therapeutic areas handling both drug and device trials.
We are dedicated to provide high quality yet personal service.
Clinical trials
Although Russian authorities received heavy criticism for approving the Sputnik V vaccine prior to the completion of Phase III clinical trials, the jab is increasingly being seen as a viable…
Russia has announced that a domestically developed COVID-19 vaccine has been approved by its health authorities, the first such approval globally. However, with large-scale Phase III trials having not yet…
Below is a selection of top stories in Russian pharma from recent months, ranging from proposed changes in legislation, labelling system updates, priorities set forth by the country’s manufacturing association…
Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening conditions. A combination of geopolitical and bureaucratic issues are restricting the flow of…
In the latest twist in the ongoing story of Russian interference in the US presidential elections of 2016, it has emerged that Russian internet trolls and automated bots spread misinformation…
In the United States, Johnson & Johnson has an image of being very close to people. Americans grow up with this company — from baby shampoo, to Tylenol when they…
You took over this organization just three months ago, having previously headed businesses in industries as diverse as retail, food, and automobiles. What drew you to Alliance Healthcare Russia? Do…
The ARPM was founded in 2002, and you were its director from 2002-2004, before leaving for a post at the Roszdravnadzor. You’ve since rejoined as director since 2007. The organization…
When Focus Reports prepared a report on the French pharmaceutical industry in 2009/10, we found that the head of the main multinational pharmaceutical association had taken a career path quite…
The U.S. and Russia have a long history of trade, and you have personally been with the American Chamber of Commerce in Russia since 2001. Can you give a brief…
The primary objectives of this association are to promote Russia as a clinical trial destination, optimize the regulatory and legislative environment, and promote the interests of ACTO members. Can you…
You have said that AstraZeneca intends to be “in Russia for Russia” and the company has recently announced a large-scale investment in this country, financing a $150Mn domestic facility in…
See our Cookie Privacy Policy Here
